Frailty Predicts Increased Mortality in Chronic Subdural Hematoma Patients

Overview

This study demonstrates that chronic subdural hematoma (CSDH) patients exhibit significantly higher long-term mortality compared to matched controls, with frailty strongly associated with this excess mortality. Frailty, characterized by cognitive impairment, frequent falls, dependency, medication use, and functional status, emerges as a key predictor of survival outcomes in CSDH.

Background

Chronic subdural hematoma is a common neurological condition in the elderly, often requiring neurosurgical intervention. Despite previous perceptions of CSDH as benign, mortality rates within 12 months post-diagnosis range from 15% to 32%, comparable to certain cancers. Frailty, a syndrome reflecting diminished physiological reserves and multisystem decline, may contribute to this increased mortality but has not been extensively studied in CSDH populations. Understanding the role of frailty could guide interventions to reduce mortality.

Data Highlights

Key Findings

• CSDH patients have a significantly higher long-term mortality compared to matched controls from the general population.
• Frailty, assessed by six clinical items including cognitive impairment and medication use, is strongly associated with increased mortality in CSDH.
• Mortality rates in CSDH patients are comparable to those seen in serious cancers such as colon carcinoma and non-Hodgkin lymphoma.
• Frailty components overlap with common risk factors for mortality in CSDH, such as comorbidity and polypharmacy.
• Frailty assessment may provide prognostic information beyond traditional clinical and radiological measures in CSDH.
• Improving frailty has been shown in other studies to reduce mortality, suggesting potential for intervention in CSDH patients.

Clinical Implications

Clinicians should consider frailty assessment as part of the evaluation of CSDH patients to better identify those at higher risk of mortality. Targeted interventions to address frailty components, such as cognitive support, fall prevention, and medication review, may improve survival outcomes. Recognizing CSDH as a sentinel event akin to hip fractures underscores the need for comprehensive geriatric management.

Conclusion

Frailty is a significant predictor of excess mortality in patients with chronic subdural hematoma, highlighting the importance of frailty assessment in this population. Addressing frailty may represent a critical step toward reducing mortality and improving long-term outcomes in CSDH.

References

1. Various Authors/Multiple Years -- Association of Frailty with Mortality Rates in Chronic Subdural Hematoma Patients